Core Alternative Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3K | Hold |
131
| – | – | 0.02% | 119 |
|
|
2025
Q1 | $63.5K | Hold |
131
| – | – | 0.02% | 123 |
|
|
2024
Q4 | $52.8K | Hold |
131
| – | – | 0.01% | 142 |
|
|
2024
Q3 | $60.9K | Hold |
131
| – | – | 0.01% | 139 |
|
|
2024
Q2 | $61.4K | Hold |
131
| – | – | 0.01% | 137 |
|
|
2024
Q1 | $54.8K | Buy |
131
+49
| +60% | +$20.5K | 0.01% | 141 |
|
|
2023
Q4 | $33.4K | Sell |
82
-109
| -57% | -$44.4K | 0.01% | 189 |
|
|
2023
Q3 | $66.4K | Buy |
191
+105
| +122% | +$36.5K | 0.01% | 167 |
|
|
2023
Q2 | $30.3K | Sell |
86
-31
| -26% | -$10.9K | ﹤0.01% | 188 |
|
|
2023
Q1 | $36.9K | Buy |
117
+43
| +58% | +$13.5K | ﹤0.01% | 177 |
|
|
2022
Q4 | $21.4K | Hold |
74
| – | – | ﹤0.01% | 211 |
|
|
2022
Q3 | $21K | Hold |
74
| – | – | ﹤0.01% | 218 |
|
|
2022
Q2 | $21K | Buy |
74
+26
| +54% | +$7.38K | 0.01% | 218 |
|
|
2022
Q1 | $13K | Buy |
48
+26
| +118% | +$7.04K | ﹤0.01% | 243 |
|
|
2021
Q4 | $5K | Buy |
+22
| New | +$5K | ﹤0.01% | 194 |
|